1Wanke, CA, Silva, M, Knox, TA, Forrester, J, Spiegelman, D, Gorbach, SL. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clinical Infectious Diseases 2000; 31 (3): 803–805.
2Tang, AM. Weight loss, wasting, and survival in HIV-positive patients: current strategies. The AIDS Reader 2003; 13 (12 Suppl.): S23–S27.
3Tang, AM, Forrester, J, Spiegelman, D, Knox, TA, Tchetgen, E, Gorbach, SL. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2002; 31 (2): 230–236.
4Arnalich, F, Martinez, P, Hernanz, A, Gonzalez, J, Plaza, MA, Montiel, C, et al. . Altered concentrations of appetite regulators may contribute to the development and maintenance of HIV-associated wasting. AIDS 1997; 11 (9): 1129–1134.
5Tang, AM, Jacobson, DL, Spiegelman, D, Knox, TA, Wanke, C. Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003. Journal of Acquired Immune Deficiency Syndromes 2005; 40 (1): 70–76.
6Melchior, JC, Niyongabo, T, Henzel, D, Durack-Bown, I, Henri, SC, Boulier, A. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. Nutrition 1999; 15 (11–12): 865–869.
7Shevitz, AH, Knox, TA, Spiegelman, D, Roubenoff, R, Gorbach, SL, Skolnik, PR. Elevated resting energy expenditure among HIV-seropositive persons receiving highly-active antiretroviral therapy. AIDS 1999; 13 (11): 1351–1357.
8Jacobson, DL, Bica, I, Knox, TA, Wanke, C, Tchetgen, E, Spiegelman, D, et al. . Difficulty swallowing and lack of receipt of highly active antiretroviral therapy predict acute weight loss in human immunodeficiency virus disease. Clinical Infectious Diseases 2003; 37 (10): 1349–1356.
9Carbonnel, F, Beaugerie, L, Abou, RA, D’Almagne, H, Rozenbaum, W, Le, QY, et al. . Macronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states. Gut 1997; 41 (6): 805–810.
10Cruess, DG, Evans, DL, Repetto, MJ, Gettes, D, Douglas, SD, Petitto, JM. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biological Psychiatry 2003; 54 (3): 307–316.
11Christensen, L, Somers, S. Comparison of nutrient intake among depressed and nondepressed individuals. International Journal of Eating Disorders 1996; 20 (1): 105–109.
12Edwards, R, Peet, M, Shay, J, Horrobin, D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. Journal of Affective Disorders 1998; 48 (2–3): 149–155.
13Peet, M. International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. British Journal of Psychiatry 2004; 184: 404–408.
14Morris, MS, Fava, M, Jacques, PF, Selhub, J, Rosenberg, IH. Depression and folate status in the US population. Psychotherapy and Psychosomatics 2003; 72 (2): 80–87.
15Rosche, J, Uhlmann, C, Froscher, W. Low serum folate levels as a risk factor for depressive mood in patients with chronic epilepsy. Journal of Neuropsychiatry and Clinical Neurosciences 2003; 15 (1): 64–66.
16Bottiglieri, T, Hyland, K, Laundy, M, Godfrey, P, Carney, MW, Toone, BK, et al. . Folate deficiency, biopterin and monoamine metabolism in depression. Psychological Medicine 1992; 22 (4): 871–876.
17Lindenbaum, J, Healton, EB, Savage, DG, Brust, JC, Garrett, TJ, Podell, ER, et al. . Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. New England Journal of Medicine 1988; 318 (26): 1720–1728.
18Burnam, MA, Wells, KB, Leake, B, Landsverk, J. Development of a brief screening instrument for detecting depressive disorders. Medical Care 1988; 26 (8): 775–789.
19Stewart, AL, Ware, JE, eds. Measuring Function and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press, 1992.
20Radloff, LN. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977; 1: 385.
21Weissman, MM, Sholomskas, D, Pottenger, M, Prusoff, BA, Locke, BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. American Journal of Epidemiology 1977; 106 (3): 203–214.
22Myers, JK, Weissman, MM. Use of a self-report symptom scale to detect depression in a community sample. American Journal of Psychiatry 1980; 137 (9): 1081–1084.
23Weissman, MM, Pilowsky, DJ, Wickramaratne, PJ, Talati, A, Wisniewski, SR, Fava, M, et al. . Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA: Journal of the American Medical Association 2006; 295 (12): 1389–1398.
24Robins, LN, Helzer, JE, Ratcliff, KS, Seyfried, W. Validity of the diagnostic interview schedule, version II: DSM-III diagnoses. Psychological Medicine 1982; 12 (4): 855–870.
25Robins, LN, Helzer, JE, Croughan, J, Ratcliff, KS. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Archives of General Psychiatry 1981; 38 (4): 381–389.
26Sherman, AM. Social relations and depressive symptoms in older adults with knee osteoarthritis. Social Science & Medicine 2003; 56 (2): 247–257.
27Ahluwalia, JS, Richter, K, Mayo, MS, Ahluwalia, HK, Choi, WS, Schmelzle, KH, et al. . African American smokers interested and eligible for a smoking cessation clinical trial: predictors of not returning for randomization. Annals of Epidemiology 2002; 12 (3): 206–212.
28Hlatky, MA, Boothroyd, D, Vittinghoff, E, Sharp, P, Whooley, MA. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA: Journal of the American Medical Association 2002; 287 (5): 591–597.
29Katz, DA, McHorney, CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. Journal of Family Practice 2002; 51 (3): 229–235.
30Foy, CG, Wickley, KL, Adair, N, Lang, W, Miller, ME, Rejeski, WJ, et al. . The Reconditioning Exercise and Chronic Obstructive Pulmonary Disease Trial II (REACT II): rationale and study design for a clinical trial of physical activity among individuals with chronic obstructive pulmonary disease. Contemporary Clinical Trials 2006; 27 (2): 135–146.
31Woods, NF, LaCroix, AZ, Gray, SL, Aragaki, A, Cochrane, BB, Brunner, RL, et al. . Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. Journal of the American Geriatrics Society 2005; 53 (8): 1321–1330.
32Sivarajan Froelicher, ES, Miller, NH, Christopherson, DJ, Martin, K, Parker, KM, Amonetti, M, et al. . High rates of sustained smoking cessation in women hospitalized with cardiovascular disease: the Women’s Initiative for Nonsmoking (WINS). Circulation 2004; 109 (5): 587–593.
33Hays, RD, Spritzer, KL, McCaffrey, D, Cleary, PD, Collins, R, Sherbourne, C, et al. . The HIV Cost and Services Utilization Study (HCSUS) Measures of Health-Related Quality of Life.DRU-1997-AHCPR. Santa Monica, CA: RAND Corporation, 1998.
34Rothman, K, Greenland, S. Modern Epidemiology. Philadelphia, PA: Lippincott Williams & Wilkins, 1998.
35Robins, JM, Greenland, S. The role of model selection in causal inference from nonexperimental data. American Journal of Epidemiology 1986; 123 (3): 392–402.
36Azizi, F, Esmaillzadeh, A, Mirmiran, P. Correlates of under- and over-reporting of energy intake in Tehranians: body mass index and lifestyle-related factors. Asia Pacific Journal of Clinical Nutrition 2005; 14 (1): 54–59.
37Rennie, KL, Jebb, SA, Wright, A, Coward, WA. Secular trends in under-reporting in young people. British Journal of Nutrition 2005; 93 (2): 241–247.
38Kim, J. The Correlates of Hunger and Reduced Dietary Intake in a Cohort of HIV-positive Adults of the Boston Area: A Cross Sectional Study with Analysis of Data Quality and Post-Recruitment Retention Rates. Boston, MA: Harvard School of Public Health, 2001.
39Ferrando, S, Evans, S, Goggin, K, Sewell, M, Fishman, B, Rabkin, J. Fatigue in HIV illness: relationship to depression, physical limitations, and disability. Psychosomatic Medicine 1998; 60 (6): 759–764.
40Ickovics, JR, Hamburger, ME, Vlahov, D, Schoenbaum, EE, Schuman, P, Boland, RJ, et al. . Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA: Journal of the American Medical Association 2001; 285 (11): 1466–1474.
41Page-Shafer, K, Delorenze, GN, Satariano, WA, JrWinkelstein, W. Comorbidity and survival in HIV-infected men in the San Francisco Men’s Health Survey. Annals of Epidemiology 1996; 6 (5): 420–430.
42Mayne, TJ, Vittinghoff, E, Chesney, MA, Barrett, DC, Coates, TJ. Depressive affect and survival among gay and bisexual men infected with HIV. Archives of Internal Medicine 1996; 156 (19): 2233–2238.